Literature DB >> 17826741

Two-pore K+ channels, NO and metabolic inhibition.

Zhongju Lu1, Junyuan Gao, Joan Zuckerman, Richard T Mathias, Glenn Gaudette, Irvin Krukenkamp, Ira S Cohen.   

Abstract

Ischemic preconditioning is a potent endogenous mechanism protecting many organs from the devastating effects of prolonged ischemia. In the heart, NO is one mediator of this myoprotective response thought to involve activation of the K(ATP) channel. Ischemic preconditioning is known to be induced by metabolic inhibition using sodium cyanide (NaCN) in single cardiomyocytes. In the present study, we show for the first time that the end effector channel activated by NaCN has been incorrectly identified. The channel activated is not K(ATP) but instead belongs to the relatively new family of two-pore domain potassium channels (K2P). Further when activated by metabolic ischemia, the amplitude of K2P current is directly modulated by activators and inhibitors of the NO pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826741      PMCID: PMC2719986          DOI: 10.1016/j.bbrc.2007.08.131

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Apoptosis recruits two-pore domain potassium channels used for homeostatic volume regulation.

Authors:  James R Trimarchi; Lin Liu; Peter J S Smith; David L Keefe
Journal:  Am J Physiol Cell Physiol       Date:  2002-03       Impact factor: 4.249

Review 2.  Physiology and pharmacology of two-pore domain potassium channels.

Authors:  Donghee Kim
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  Both metabolic inhibition and mitochondrial K(ATP) channel opening are myoprotective and initiate a compensatory sarcolemmal outward membrane current.

Authors:  Hiroshi Irie; Junyuan Gao; Glenn R Gaudette; Ira S Cohen; Richard T Mathias; Adam E Saltman; Irvin B Krukenkamp
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

Review 5.  Molecular and functional properties of two-pore-domain potassium channels.

Authors:  F Lesage; M Lazdunski
Journal:  Am J Physiol Renal Physiol       Date:  2000-11

6.  Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel.

Authors:  M Fink; F Duprat; F Lesage; R Reyes; G Romey; C Heurteaux; M Lazdunski
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

7.  Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species.

Authors:  F Duprat; C Girard; G Jarretou; M Lazdunski
Journal:  J Physiol       Date:  2004-10-28       Impact factor: 5.182

8.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

9.  Priming effect of adenosine on K(ATP) currents in intact ventricular myocytes: implications for preconditioning.

Authors:  Y Liu; W D Gao; B O'Rourke; E Marban
Journal:  Am J Physiol       Date:  1997-10

10.  Isoprenaline, Ca2+ and the Na(+)-K+ pump in guinea-pig ventricular myocytes.

Authors:  J Gao; R T Mathias; I S Cohen; G J Baldo
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

View more
  2 in total

1.  Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.

Authors:  J Gierten; E Ficker; R Bloehs; K Schlömer; S Kathöfer; E Scholz; E Zitron; C Kiesecker; A Bauer; R Becker; H A Katus; C A Karle; D Thomas
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

Review 2.  Nitric Oxide and Mechano-Electrical Transduction in Cardiomyocytes.

Authors:  Hannah E Boycott; My-Nhan Nguyen; Besarte Vrellaku; Katja Gehmlich; Paul Robinson
Journal:  Front Physiol       Date:  2020-12-15       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.